Becquemont L, Nguyen G, Peraldi M N, He C J, Sraer J D, Rondeau E
Institut National de la Santé et de la Recherche Médicale U 64, Hôpital Tenon, Paris, France.
Am J Physiol. 1994 Aug;267(2 Pt 2):F303-10. doi: 10.1152/ajprenal.1994.267.2.F303.
The aim of the present study was to display plasminogen/plasmin receptors on human glomerular epithelial cell (HGEC) membranes and to determine the properties of receptor-bound plasminogen at the cell surface. Using an immortalized human glomerular epithelial cell line (E71-A1), we found a specific, saturable, and reversible binding of 125I-labeled plasminogen and 125I-labeled plasmin to HGEC that involved the lysine binding sites of both ligands. 125I-plasminogen and 125I-plasmin bound to the same receptors with different affinities: Kd = 1.20 +/- 0.08 and 0.30 +/- 0.05 microM, respectively (P < 0.001). The number of binding sites per cell was 6.00 +/- 0.56 x 10(6) for plasminogen and 2.00 +/- 0.47 x 10(6) for plasmin (P < 0.05). Similar receptor affinities were found on isolated glomeruli, on immortalized and nonimmortalized HGEC, and on purified HGEC membranes. The apparent kinetic constants of plasminogen activation by receptor-bound urokinase-type plasminogen activator (u-PA) compared with solution-phase u-PA [Michaelis constant (Km) = 0.80 +/- 0.54 vs. 3.15 +/- 0.78 microM, P < 0.0001; catalytic constant (kcat) = 0.39 +/- 0.17 vs. 0.50 +/- 0.29 s-1, not significant; kcat/Km = 0.57 +/- 0.35 vs. 0.16 +/- 0.11 microM-1.s-1, P < 0.05, respectively] showed a higher efficiency of plasminogen activation at the cell surface. When measured by a chromogenic assay using S22-51, receptor-bound plasmin activity on HGEC was partly protected from its inhibitor, alpha-2-antiplasmin, whereas solution-phase plasmin was not.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是展示人肾小球上皮细胞(HGEC)膜上的纤溶酶原/纤溶酶受体,并确定细胞表面受体结合型纤溶酶原的特性。使用永生化人肾小球上皮细胞系(E71-A1),我们发现125I标记的纤溶酶原和125I标记的纤溶酶与HGEC存在特异性、可饱和且可逆的结合,这涉及两种配体的赖氨酸结合位点。125I-纤溶酶原和125I-纤溶酶以不同亲和力结合相同受体:解离常数(Kd)分别为1.20±0.08和0.30±0.05微摩尔(P<0.001)。每个细胞的结合位点数,纤溶酶原为6.00±0.56×10(6),纤溶酶为2.00±0.47×10(6)(P<0.05)。在分离的肾小球、永生化和非永生化HGEC以及纯化的HGEC膜上发现了相似的受体亲和力。与溶液相尿激酶型纤溶酶原激活剂(u-PA)相比,受体结合型u-PA激活纤溶酶原的表观动力学常数[米氏常数(Km)=0.80±0.54对3.15±0.78微摩尔,P<0.0001;催化常数(kcat)=0.39±0.17对0.50±0.29秒-1,无显著差异;kcat/Km=0.57±0.35对0.16±0.11微摩尔-1·秒-1,P<0.05]表明细胞表面纤溶酶原激活效率更高。当使用S22-51通过显色测定法测量时,HGEC上受体结合型纤溶酶活性部分受到其抑制剂α-2-抗纤溶酶的保护,而溶液相纤溶酶则不受保护。(摘要截短于250字)